Jennifer G. Whisenant
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jennifer G. Whisenant has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Cathy Eng
Division of Hematology & Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37235, USA
46 shared publications - Dana Backlund Cardin
Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA
45 shared publications - Gregory D. Ayers
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee
45 shared publications - Jordan Berlin
17Vanderbilt University Medical Center, Nashville, Tennessee
45 shared publications - Kristen Keon Ciombor
Division of Hematology & Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
45 shared publications - Alexey Sorokin
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
44 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S8 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
Table S8 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
Table S8 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S4 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
Table S4 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
Table S4 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S5 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
Table S5 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
Table S5 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer